Streetbeat News

Equity Actions

LLY

VERV

Verve Therapeutics has announced a public offering of its common stock, with an additional 30-day option for underwriters to purchase up to 15% more shares. Eli Lilly and Company is expected to buy up to $35 million of Verve's stock, provided it doesn't exceed a 4.9% ownership stake.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 9:05 pm

BRK.A

BRK.B

Charlie Munger, a key member of Berkshire Hathaway Inc., has passed away peacefully this morning at a California hospital, as reported by Reuters and advised by members of Munger's family.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 8:58 pm

TMO

Thermo Fisher Scientific Inc. (NYSE:TMO) saw a 0.68% drop in its share price to $486.80 in the current market session. Despite a 9.45% increase over the past month, the stock has decreased by 13.11% over the past year. The company's P/E ratio of 32.12 is lower than the industry average of 37.9, which could suggest it is undervalued or expected to underperform compared to its peers in the Life Sciences Tools & Services industry.

Portfolio Pulse from Benzinga Insights

November 28, 2023 | 8:30 pm

DIS

Disney CEO Bob Iger, speaking at a company town hall, acknowledged the challenges faced since his return were greater than anticipated. He downplayed the likelihood of major asset sales and expressed his commitment to building a modern version of the company.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 8:15 pm

IBIO

iBio, Inc. (NASDAQ:IBIO) has announced a 20-to-1 reverse stock split effective November 29, 2023. Shareholders will receive one new share for every 20 old shares, with fractional shares paid out in cash. The reverse split aims to reduce the number of outstanding shares, and adjustments will be made to stock options, warrants, and equity plans. Shareholders with physical stock certificates will receive instructions for exchange, while those with brokerage accounts need not take any action. iBio's 52-week trading range is between $0.20 and $2.60.

Portfolio Pulse from Henry Khederian

November 28, 2023 | 8:01 pm

NUE

Nucor Corporation (NYSE:NUE) has experienced a 3.55% increase in short interest since its last report, with 5.38 million shares sold short, representing 2.92% of its float. The current short interest suggests a bearish sentiment among investors, but it's not a definitive indicator of a future price drop. Nucor's short interest is below its peer group average of 4.30%. Short interest can be a complex indicator, as increasing short interest can sometimes be bullish for a stock.

Portfolio Pulse from Benzinga Insights

November 28, 2023 | 8:00 pm

ADSK

Autodesk's (NYSE:ADSK) short interest has increased by 12.87% since the last report, with 2.43 million shares sold short, representing 1.14% of available shares. It would take 2.23 days to cover these short positions based on current trading volume. While an increase in short interest can indicate bearish sentiment, it does not necessarily predict a near-term price drop. Autodesk has less short interest compared to its peer group average of 3.36%.

Portfolio Pulse from Benzinga Insights

November 28, 2023 | 8:00 pm

CABA

CREV

ICCM

PDD

SNES

THAR

U.S. stocks saw gains with the Dow Jones rising by 0.27%, NASDAQ by 0.12%, and S&P 500 by 0.07%. Consumer discretionary shares led the gains, while health care shares declined. Crude oil surged by 2.1%, and gold also rose. Carbon Revolution, PDD Holdings, and IceCure Medical saw significant stock price increases following positive news. Tharimmune's shares plummeted after pricing a public offering at $1 per share. SenesTech and Cabaletta Bio also experienced sharp declines in their share prices.

Portfolio Pulse from Lisa Levin

November 28, 2023 | 7:57 pm

NOC

Northrop Grumman (NYSE:NOC) has seen a 9.57% increase in short interest since the last report, with 1.56 million shares sold short, representing 1.03% of available shares. The average time to cover these short positions is 1.71 days. While an increase in short interest can indicate bearish sentiment, it does not necessarily predict a stock price decline. Northrop Grumman's short interest is below its peer group average of 3.00%.

Portfolio Pulse from Benzinga Insights

November 28, 2023 | 7:45 pm

MS

Morgan Stanley's (NYSE:MS) short interest has increased by 5.0% since the last report, with 21.13 million shares sold short, representing 1.68% of available shares. It would take 2.21 days to cover these short positions. While an increase in short interest can indicate bearish sentiment, it doesn't necessarily predict a near-term price drop. Morgan Stanley's short interest is below its peer group average of 4.08%.

Portfolio Pulse from Benzinga Insights

November 28, 2023 | 7:45 pm